EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Aberrant HCN4 channel expression: Impacts on neuronal excitability and implications for epilepsy pathogenesis

James Spyrou iD, Iris Escobar, Angélique Bordey, Christopher A Reid

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.70218 ↗

At a glance

Übersichtsarbeit in British Journal of Pharmacology, 2025. Written by James Spyrou and 3 co-authors. Institution: The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia. Major MEDLINE topics: Epilepsy, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels, Neurons. Cited 1 times so far (Crossref); 92 references. Funded by: Australian Government Research Training Program Scholarship.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Hyperpolarisation‐activated cyclic nucleotide‐gated (HCN) channels are nonselective voltage‐gated cation channels encoded by four genes ( HCN1‐4 ) that show distinct localisation patterns throughout the central nervous system and body. Among the four isoforms, HCN4 channels are most widely known for their pacemaker activity in cardiac tissue, with HCN4 pathogenic variants being strongly associated with cardiac abnormalities. In the brain, HCN4 channels are predominantly expressed in subcortical regions, where they play roles in regulating brain function including controlling transmitter release, burst firing, and neuronal network oscillatory activity. HCN4 channels also have been proposed as important modulators of general seizure susceptibility. Importantly, accumulating evidence points to HCN4 channel involvement in the aetiology of hyperexcitability in focal cortical dysplasia and tuberous sclerosis. In this review, we have explored the function of HCN4 channels in the brain, focusing on their key roles in modulating both individual neuron and network‐level excitability. More specifically, we have examined the canonical functions of HCN4 channels in regulating rhythmic and oscillatory activity. We have discussed the evidence, from both the clinic and animal modelling, linking aberrant HCN4 channel expression with epilepsy, and evaluated the targeting of HCN4 channels as a potential therapeutic strategy for seizure control.

Subjects

MeSH terms (MEDLINE)

EpilepsyHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsNeuronsHumansAnimalsBrainMuscle ProteinsPotassium Channels

Author keywords

HCN channelscortical dysplasiacortical malformationepilepsyhyperpolarisationion channelsneurodevelopmental disorderseizurestuberous sclerosis complex

Substances

Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsHCN4 protein, humanMuscle ProteinsPotassium Channels

Authors and institutions

  • The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
  • Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.
  • Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.

ORCID profiles: James Spyrou

Funding

  • Australian Government Research Training Program Scholarship

Cite

APA

Spyrou, J., Escobar, I., Bordey, A., & Reid, C. A. (2025). Aberrant HCN4 channel expression: Impacts on neuronal excitability and implications for epilepsy pathogenesis. British Journal of Pharmacology. https://doi.org/10.1111/bph.70218

Vancouver

Spyrou J, Escobar I, Bordey A, Reid CA. Aberrant HCN4 channel expression: Impacts on neuronal excitability and implications for epilepsy pathogenesis. British Journal of Pharmacology. 2025. doi:10.1111/bph.70218

BibTeX
@article{Spyrou2025,
  author = {Spyrou, James and Escobar, Iris and Bordey, Angélique and Reid, Christopher A},
  title = {Aberrant HCN4 channel expression: Impacts on neuronal excitability and implications for epilepsy pathogenesis},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.70218}
}
Start for free →